The Food and Drug Administration will begin posting every three months a list of drugs whose safety is under investigation because of complaints brought to the agency's attention by drug companies, physicians and patients.
The FDA will name the drug and the nature of the "adverse events" but will not describe their seriousness or the number of complaints received, officials said yesterday.
FDA to List Drugs Being Investigated
The Supreme Court on June 30 declined to to hear a censorship complaint brought by Health...
